Use of Thermography for the Prevention and Diagnosis of Diabetic Foot
Launched by UNIVERSITY OF SEVILLE · Jun 28, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a technique called infrared thermography to help prevent and diagnose diabetic foot, a serious condition that can occur in people with diabetes. Diabetic foot can lead to painful sores and infections, and in severe cases, it can even result in amputations. The goal of the study is to see if measuring skin temperature differences in the feet can help identify problems early, which may prevent these complications. Researchers will compare the foot temperatures of healthy individuals to those with diabetic foot to determine how effective this method is.
To participate in the trial, you need to be between 40 and 80 years old and have either type 1 or type 2 diabetes. Both men and women can join, but you should not have any recent skin conditions that might affect the results, nor should you have had any recent treatments that impact blood flow to the legs. If eligible, you’ll be asked to sign a consent form. Although the trial is not yet recruiting participants, it aims to provide valuable insights into a non-invasive way to keep an eye on foot health for those living with diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects of both sexes. Age between 40 and 80 years. Diagnosis of type 1 or type 2 diabetes mellitus (for the case group). Absence of acute inflammatory diseases in the control group. Signed informed consent.
- Exclusion Criteria:
- • Skin diseases that affect the interpretation of thermography. Recent treatment with medications that affect peripheral circulation. History of lower limb amputation.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
RAQUEL GARCIA DE LA PEÑA, DOCTOR
Principal Investigator
University of Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported